Wire Screener Dashboard Go Pro

Watchlist

--

--

--

--

Get Started Log In Not investment advice. Past performance ≠ future results.

Loading…

Wire Screener Dashboard

APGE Apogee Therapeutics, Inc. Stock — fundamentals, financials & AI research · AlgoThesis

Stocks›Basic Materials›APGE

APGE

Apogee Therapeutics, Inc.

NasdaqResearch view

Basic Materials · Biological Products, (No Diagnostic Substances)

OverviewFundamentals Latest filings ↗

Price history

Interactive · live data via TradingView

🔒 Click to interact · scroll moves the page

Snapshot

SEC EDGAR

Revenue—

Net Income—

Gross Profit—

Oper Income—

EPS (dil)—

Rev/sh—

FCF/sh—

Book/sh—

Cash/sh—

Gross M—

Oper M—

Profit M—

FCF M—

ROE—

ROA—

ROIC—

R&D/Rev—

Rev Y/Y—

Rev 3Y CAGR—

EPS Y/Y—

EPS 3Y CAGR—

FCF 3Y CAGR—

Payout—

Div/sh—

Shs Chg Y/Y—

Current Ratio—

Quick Ratio—

Debt/Eq—

Int Coverage—

Net Debt—

Total Debt—

Cash & Eq—

Total Assets—

Oper CF—

Capex—

Free CF—

Buybacks—

Equity—

Liabilities—

Shs Outstand—

SectorBasic Materials

🔒 P/E—

🔒 Fwd P/E—

🔒 P/S—

🔒 P/B—

🔒 Market Cap—

🔒 Div Yield—

🔒 52W Range—

🔒 Beta—

40+ fundamentals from SEC EDGAR (public domain) — deeper than a typical screener's ratio table.

Revenue & Earnings — fiscal year

Revenue history unavailable.

COMMUNITY · $APGE0 theses

POST YOUR TAKE →

Related Stocks

Loading peers…

Ask AI about APGE Build basket with APGE Screener

Fundamentals sourced from SEC EDGAR filings (public domain). For informational purposes only. Not investment advice.